Immuno-Biological Laboratories Co., Ltd. engages in the manufacture and sale of antibody-related reagents and pharmaceutical products. It operates through the following segments: Diagnostics and Reagents, Genetically Modified Silkworm, Testing, and Cosmetics-related. The Diagnostics and Reagents segment deals with the research and development of reagents and pharmaceutical products as well as in vitro diagnostic pharmaceuticals. The Genetically Modified Silkworm segment sells products using the cocoon of genetically modified silkworm. The Testing segment offers prevention and diagnostic support on top of drug discovery and research support in lifestyle-related diseases using lipid metabolism analysis technology. The Cosmetics-related segment develops and manufactures cosmetic products containing Neosilk-Human Collagen I. The company was founded on September 9, 1982 and is headquartered in Fujioka, Japan.
公司网站 :
http://www.ibl-japan.co.jp
总经理:-
建立时间:1982
公司总部:Fujioka
领域:Health technology
行业:Medical specialties